Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Scf Couto"'
Autor:
VJ Silva, IC Ovider, A Azevedo, IS Filgueira, GA Martinez, FS Seguro, O Cabral-Marques, SCF Couto, TGM Oliveira, RR Almeida, JAM Barbuto, VG Rocha, RN Ramos
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S547- (2023)
Introduction: Our previous study demonstrated that monocytes from breast cancer patients display alterations in their transcriptomic profile that include the down regulation of genes involved in their differentiation and in their ability to stimulate
Externí odkaz:
https://doaj.org/article/c57a01c5385d4a5b9393cf74da5d3934
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S988-S989 (2023)
Background: T lymphocytes expressing chimeric antigen receptors (CAR) have been shown to be efficient for tretment of hematologic, but less efficient for solid tumors, due to the great complexity of the tumor microenvironment involving: heterogeneity
Externí odkaz:
https://doaj.org/article/9bdec0b824504e2e9373f0a019d5070a
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S271- (2021)
Introduction: Anti-CD19 CAR-T cell therapy has been associated with improved outcomes in R/r DLBCL. In Brazil, management of patients treated with this therapy can be cumbersome due to the lack of experience with this therapeutic product in most cent
Externí odkaz:
https://doaj.org/article/0fcd680e7d994e19bc4be5b92d26cd4c
Autor:
Marcos de Lima, Scf Couto, AM Ferreira, Tgm Oliveira, Lcb Mariano, Nelson Hamerschlak, Rodrigo Nalio Ramos, Vanderson Rocha
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss, Pp S271-(2021)
Introduction Anti-CD19 CAR-T cell therapy has been associated with improved outcomes in R/r DLBCL. In Brazil, management of patients treated with this therapy can be cumbersome due to the lack of experience with this therapeutic product in most cente
Autor:
MPO Lima, SCF Couto, PDAC Ribeiro, VJ Silva, IAP Lemos, FA Ros, TGM Oliveira, RN Ramos, AM Junior, V Rocha
Publikováno v:
Hematology, Transfusion and Cell Therapy. 44:S295
Publikováno v:
Hematology, Transfusion and Cell Therapy. 44:S317
Autor:
IAP Lemos, VJ Silva, TGM Oliveira, SCF Couto, GA Martinez, FS Seguro, JAM Barbuto, OC Marques, V Rocha, RN Ramos
Publikováno v:
Hematology, Transfusion and Cell Therapy. 44:S312
Autor:
VJ Silva, IAP Lemos, SCF Couto, TGM Oliveira, GA Martinez, FS Seguro, OC Marques, JAM Barbuto, V Rocha, RN Ramos
Publikováno v:
Hematology, Transfusion and Cell Therapy. 44:S250
Autor:
Rós FA; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil; Postgraduate program in Medical Science, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil. Electronic address: felipe.ros@usp.br., Couto SCF; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil; Fundação Pró-Sangue-Hemocentro de Sao Paulo, São Paulo, Brazil., Milhomens J; Center for Cell-Based Therapy, Regional Blood Center of Ribeirão Preto, Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Ribeirão Preto, Brazil., Ovider I; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil; Postgraduate program in Medical Science, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil., Maio KT; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil; Hospital Israelita Albert Einstein, São Paulo, Brazil., Jennifer V; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil; Postgraduate program in Medical Science, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil., Ramos RN; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil; Instituto D'Or de Ensino e Pesquisa, São Paulo, Brazil., Picanço-Castro V; Center for Cell-Based Therapy, Regional Blood Center of Ribeirão Preto, Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Ribeirão Preto, Brazil., Kashima S; Center for Cell-Based Therapy, Regional Blood Center of Ribeirão Preto, Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Ribeirão Preto, Brazil., Calado RT; Center for Cell-Based Therapy, Regional Blood Center of Ribeirão Preto, Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Ribeirão Preto, Brazil., Barros LRC; Center for Translational Research in Oncology, Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Rocha V; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil; Fundação Pró-Sangue-Hemocentro de Sao Paulo, São Paulo, Brazil; Center for Translational Research in Oncology, Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil; Churchill Hospital, Department of Hematology, Churchill Hospital, University of Oxford, Oxford, United Kingdom.
Publikováno v:
Cytotherapy [Cytotherapy] 2023 Dec; Vol. 25 (12), pp. 1300-1306. Date of Electronic Publication: 2023 Jun 15.
Autor:
Couto SCF; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology and Cell Therapy, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.; Fundação Pró-Sangue-Hemocentro de São Paulo, São Paulo, Brazil., Kowes A; Fundação Pró-Sangue-Hemocentro de São Paulo, São Paulo, Brazil., Aurabi CS; Fundação Pró-Sangue-Hemocentro de São Paulo, São Paulo, Brazil., Oliveira TGM; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology and Cell Therapy, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.; Fundação Pró-Sangue-Hemocentro de São Paulo, São Paulo, Brazil., Klinger P; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology and Cell Therapy, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil., Rocha V; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology and Cell Therapy, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.; Fundação Pró-Sangue-Hemocentro de São Paulo, São Paulo, Brazil.; Instituto D'Or de Ensino e Pesquisa, São Paulo, Brazil.
Publikováno v:
Frontiers in oncology [Front Oncol] 2023 Aug 30; Vol. 13, pp. 1195759. Date of Electronic Publication: 2023 Aug 30 (Print Publication: 2023).